![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
Drugs Approved for Different Types of Cancer
Drugs approved by the FDA for specific types of cancer are listed on this page. The drug names link to NCI's information summaries about these drugs. The pages are updated when new cancer drugs are approved. See Drugs Approved for Childhood Cancers for a list specific to children. Find drugs approved by the FDA for specific types of cancer.
A to Z List of Cancer Drugs - National Cancer Institute
Use the A to Z list below to find consumer-friendly information about drugs for cancer and conditions related to cancer. The list is in alphabetical order by generic name and brand name. You can also find this information on our pages organized by cancer type and …
Targeted Therapy Drug List by Cancer Type - NCI - National Cancer …
Targeted therapy is a type of cancer treatment that targets the changes in cancer cells that help them grow, divide, and spread. Learn more about targeted therapy drugs that have been approved by the FDA to treat specific types of cancer.
Breaking Down Cancer Therapies Approved by the FDA in …
2025年2月3日 · It was announced on Jan. 27 that the antibody drug conjugate Enhertu was granted FDA approval for the treatment of patients with unresectable or metastatic HR-positive, HER2-low or -ultralow breast cancer following disease progression on one or more endocrine therapies in the metastatic setting.
Oncology (Cancer)/Hematologic Malignancies Approval Notifications - FDA
FDA does not issue approval announcements for every approval or drug label update that occurs in oncology and hematology. Please refer to Drugs@FDA for the latest approvals and...
Ongoing | Cancer Accelerated Approvals | FDA - U.S. Food and Drug …
2024年12月5日 · This listing includes accelerated approvals (AAs) for malignant hematology and oncology indications that have postmarketing requirement (s) for ongoing clinical trial (s) to verify clinical...
Breakthrough Therapies - Friends of Cancer Research
As of June 30, 2024, the FDA has approved 317* breakthrough therapy designated products and lists that there have been 1516 total requests for the designation with 587 designations granted. Treatment of IgA nephropathy (IgAN). Treatment of PIK3CA-mutated breast cancer.
Verified Clinical Benefit | Cancer Accelerated Approvals | FDA
2024年9月30日 · This listing includes accelerated approvals (AAs) for malignant hematology and oncology indications with postmarketing trials that have verified clinical benefit and for which traditional...
Oncology Drug Approvals: 2023 Recap - Cancer Therapy Advisor
2024年1月16日 · The US Food and Drug Administration (FDA) approved a range of oncology drugs in 2023. See the tables below for details on approvals by month.
Cancer Therapies Approved by the FDA in December 2024
2025年1月2日 · Throughout December, the Food and Drug Administration (FDA) approved several oncology drugs for the treatment of cancers including pancreatic, lung and skin. Here is a select list of cancer therapies approved by the FDA last month.